BioPharma Pharma Research

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

 September 18, 2023 | News

BioRay's Zuberitamab (Anruixi®) First Domestic Anti-CD20 Antibody Approved in China

In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...

 September 14, 2023 | News

Takara Bio Europe Launches Enzymes for mRNA Vaccine R&D

Takara Bio Europe (TBE) announced  the launch of new High Quality (HQ) grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatas...

 September 13, 2023 | News

Waters Introduces Simplified Solutions for Biologic Drug Analysis

  Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...

 September 13, 2023 | News

IPMG Accelerates Access to Innovative Medicines, Boosts Indonesia's Economy Through Partnerships

The limited availability of new drugs and vaccines is a challenge in presenting new hope for Indonesians for innovative therapeutic options with the latest...

 September 12, 2023 | News

Verily and Kyverna Collaborate to Advance Cell Therapy for Autoimmune Diseases

Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company engineering a new clas...

 September 08, 2023 | News

Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore

Agilent Technologies Inc. (NYSE: A) recently signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institu...

 September 05, 2023 | News

China-Africa medical cooperation broadens under BRI

From there, he can admire the breathtaking views of the sleek, curved structure and the intricately layered sunshade components, showcasing the marvels of ...

 September 04, 2023 | News

ABM Therapeutics Initiates Phase I Study of ABM-1310 in BRAF V600 Brain Tumors

ABM-1310, the company's proprietary clinical candidate developed as a next-generation BRAF inhibitor and demonstrated superior properties in pre-clinical a...

 September 04, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company,  announced the completion of an $18 million Series Pre-A financing. The financ...

 September 04, 2023 | News

Elevating Energy Efficiency and Sustainability in the Pharmaceutical Industry

Explore an in-depth conversation with Jackson Seng as he sheds light on the successful partnership between Schneider Electric and Takeda, leading to the es...

 August 31, 2023 | News

Epigenic Therapeutics Raises $32M for Breakthrough Epigenome Medicine Development

This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expa...

 August 30, 2023 | News

GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics

Under the MOU, both parties agreed to cooperate for a successful supply of the vaccine. While Eubiologics, a developer and producer of Euvichol, takes char...

 August 28, 2023 | News

BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research

The newly developed XDC bioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizin...

 August 25, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in